ReGen’s cognitive enhancing nutraceutical product Colostrinin has been launched in its first market, Australasia, and the company is now in full-scale commercial production. The active ingredient is being manufactured in North America, with production set to supply Australasia as well as the US. Colostrinin is on track for US launch in Q4 2007.

Unlock the rest of this article with a 14 day trial

or Unlock with your email

Already have an account?
Login here